Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.36 |
| ▸ | CTSS | P25774 | 5/20 | 0.34 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30338778 | 1.00 | GPR119 (0.36) | GPR119CTSSUSP30 | |
| SCHEMBL25816465 | 0.85 | CHRM2 (0.33) | GPR119USP30 | |
| SCHEMBL25816719 | 0.83 | GPR119 (0.32) | GPR119USP30 | |
| SCHEMBL30338715 | 0.83 | GPR119 (0.32) | GPR119USP30 | |
| SCHEMBL29048231 | 0.82 | GPR119 (0.39) | GPR119CTSSUSP30 | |
| SCHEMBL30338636 | 0.82 | GPR119 (0.39) | GPR119CTSSUSP30 | |
| SCHEMBL25816640 | 0.82 | GPR119 (0.39) | GPR119CTSSUSP30 | |
| SCHEMBL30338608 | 0.79 | GPR119 (0.43) | GPR119USP30 | |
| SCHEMBL25816507 | 0.79 | GPR119 (0.43) | GPR119USP30 | |
| SCHEMBL30547535 | 0.79 | GPR119 (0.40) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116547281-A | Isoxazolidines as RIPK1 inhibitors and uses thereof | 赛诺菲 | 2023-08-04 | — | — | CN | disclosed |
| US-20230219937-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | SANOFI (FR) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219937-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | RIPK1, RIPK4, RIPK2 | GPR119 420/4885CTSS 4705/4885USP30 1354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.